Sex-specific associations between placental corticotropin releasing hormone and problem behaviors in childhood.


Journal

Psychoneuroendocrinology
ISSN: 1873-3360
Titre abrégé: Psychoneuroendocrinology
Pays: England
ID NLM: 7612148

Informations de publication

Date de publication:
May 2024
Historique:
received: 01 11 2023
revised: 13 02 2024
accepted: 14 02 2024
medline: 18 3 2024
pubmed: 23 2 2024
entrez: 22 2 2024
Statut: ppublish

Résumé

Placental corticotropin-releasing hormone (pCRH) is a neuroactive peptide produced in high concentrations in mid-late pregnancy, during key periods of fetal brain development. Some evidence suggests that higher pCRH exposure during gestation is associated with adverse neurodevelopment, particularly in female offspring. In 858 mother-child dyads from the sociodemographically diverse CANDLE cohort (Memphis, TN), we examined: (1) the slope of pCRH rise in mid-late pregnancy and (2) estimated pCRH at delivery as a measure of cumulative prenatal exposure. When children were 4 years-old, mothers reported on problem behaviors using the Child Behavior Checklist (CBCL) and cognitive performance was assessed by trained psychologists using the Stanford-Binet Intelligence Scales. We fitted linear regression models examining pCRH in relation to behavioral and cognitive performance measures, adjusting for covariates. Using interaction models, we evaluated whether associations differed by fetal sex, breastfeeding, and postnatal neighborhood opportunity. In the full cohort, log-transformed pCRH measures were not associated with outcomes; however, we observed sex differences in some models (interaction p-values≤0.01). In male offspring, an interquartile (IQR) increase in pCRH slope (but not estimated pCRH at delivery), was positively associated with raw Total (β=3.06, 95%CI: 0.40, 5.72), Internalizing (β=0.89, 95%CI: 0.03, 1.76), and Externalizing (β=1.25, 95%CI: 0.27, 2.22) Problem scores, whereas, in females, all associations were negative (Total Problems: β=-1.99, 95%CI: -3.89, -0.09; Internalizing: β=-0.82, 95%CI: -1.42, -0.23; Externalizing: β=-0.56, 95%CI: -1.34, 0.22). No associations with cognitive performance were observed nor did we observe moderation by breastfeeding or postnatal neighborhood opportunity. Our results provide further evidence that prenatal pCRH exposure may impact subsequent child behavior in sex-specific ways, however in contrast to prior studies suggesting adverse impacts in females, steeper mid-gestation pCRH rise was associated with more problem behaviors in males, but fewer in females.

Identifiants

pubmed: 38387218
pii: S0306-4530(24)00038-6
doi: 10.1016/j.psyneuen.2024.106994
pii:
doi:

Substances chimiques

Corticotropin-Releasing Hormone 9015-71-8

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

106994

Informations de copyright

Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None.

Auteurs

Emily S Barrett (ES)

Department of Biostatistics and Epidemiology, Rutgers School of Public Health, Piscataway, NJ, USA; Environmental and Occupational Health Sciences Institute, Rutgers University, Piscataway, NJ, USA. Electronic address: Emily.barrett@eohsi.rutgers.edu.

Alexandra Sullivan (A)

Center for Health and Community, University of California, San Francisco, CA, USA; Department of Psychiatry and Behavioral Sciences, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA.

Tomomi Workman (T)

Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, USA.

Yuhong Zhang (Y)

Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, USA.

Christine T Loftus (CT)

Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, USA.

Adam A Szpiro (AA)

Department of Biostatistics, University of Washington, Seattle, WA, USA.

Alison Paquette (A)

Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, USA; Seattle Children's Research Institute, Seattle, WA, USA; Department of Pediatrics, University of Washington, Seattle, WA, USA.

James W MacDonald (JW)

Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, USA.

Michael Coccia (M)

Center for Health and Community, University of California, San Francisco, CA, USA.

Roger Smith (R)

Mothers and Babies Research Centre, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia.

Maria Bowman (M)

Mothers and Babies Research Centre, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia.

Alicia Smith (A)

Department of Gynecology and Obstetrics, Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, USA.

Karen Derefinko (K)

Department of Preventive Medicine, University of Tennessee Health Sciences Center, Memphis, TN, USA.

Ruby H N Nguyen (RHN)

Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, MN, USA.

Qi Zhao (Q)

Department of Preventive Medicine, University of Tennessee Health Sciences Center, Memphis, TN, USA.

Sheela Sathyanarayana (S)

Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, USA; Seattle Children's Research Institute, Seattle, WA, USA; Department of Pediatrics, University of Washington, Seattle, WA, USA; Department of Epidemiology, University of Washington, Seattle, WA, USA.

Catherine Karr (C)

Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, USA; Department of Pediatrics, University of Washington, Seattle, WA, USA; Department of Epidemiology, University of Washington, Seattle, WA, USA.

Kaja Z LeWinn (KZ)

Department of Psychiatry and Behavioral Sciences, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA.

Nicole R Bush (NR)

Center for Health and Community, University of California, San Francisco, CA, USA; Department of Psychiatry and Behavioral Sciences, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA; Department of Pediatrics, University of California San Francisco, San Francisco, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH